To examine whether intravenous TXA administration enhances analgesia or contributes to hyperalgesia in patients undergoing laparoscopic radical prostatectomy, with a focus on pain management outcomes.
Key Findings:
VAS scores at 0th and 6th hours were significantly lower in the control group compared to the TXA group, indicating a potential difference in pain management efficacy.
No significant differences in VAS scores were observed at 12th and 24th hours between groups, suggesting similar long-term pain outcomes.
The TXA group required more rescue analgesia and had a shorter time to first rescue analgesia requirement, indicating a potential increase in pain sensitivity.
Interpretation:
TXA administration may not provide effective analgesia and could be associated with increased pain sensitivity postoperatively, warranting further investigation.
Limitations:
Small sample size may limit generalizability of the findings.
Observational design does not establish causation and may introduce biases.
Conclusion:
TXA may not enhance postoperative analgesia and could be associated with increased analgesic requirements in laparoscopic radical prostatectomy, suggesting a need for careful consideration in clinical practice.
